Direct Pulp Capping Versus Pulpotomy for Primary Molars
Launched by KING ABDULLAH UNIVERSITY HOSPITAL · May 7, 2025
Trial Information
Current as of November 06, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This study is comparing two ways to treat exposed pulp (the nerve inside a tooth) in baby teeth with deep decay. One method is direct pulp capping (DPC), where the exposed pulp is covered and kept intact. The other is pulpotomy, where the top part of the pulp is removed but the tooth is kept alive. Both treatments use Neo MTA, a specific dental cement, and the tooth is restored with a crown afterward. It’s a split-mouth trial, meaning each child will receive both treatments on different baby molars, with about a 1–2 week gap between visits. Children will be followed for up to 24 months to check that the treated teeth stay symptom-free and show no new problems on X-rays.
Who can join: healthy children aged 4–10 with deep caries in primary molars that are restorable and either asymptomatic or have mild reversible pulpitis. X-rays should show the decay has reached near the pulp but not caused irreversible damage. Exclusion criteria include spontaneous tooth pain, mobile or loose teeth, no pulp exposure after digging out the decay, or difficulty stopping any bleeding within 6 minutes. The study aims to enroll about 60 participants and is currently enrolling by invitation at King Abdullah University Hospital in Irbid, Jordan. If you participate, you’ll have two treatment visits and regular follow-ups for up to 2 years; results about which method works better are not yet known.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Healthy patients.
- • Age 4-10 years.
- • Primary molar with deep caries present bilaterally.
- • Teeth should be restorable.
- • Clinically normal asymptomatic tooth or symptoms of reversible pulpitis (No history of pain or provoked pain subsides upon removal of the stimulus).
- • Radiographically: caries in the inner half of the dentin approaching the pulp.
- Exclusion Criteria:
- • History of spontaneous pain.
- • Soft and hard tissue pathology.
- • Mobility or exfoliating tooth.
- • No pulp exposure after caries excavation.
- • Inability to achieve hemostasis after 6 minutes.
- • Radiographically: Root resorption exceeding 1/3 of the root, apical pathology.
About King Abdullah University Hospital
King Abdullah University Hospital (KAUH) is a leading medical institution dedicated to advancing healthcare through innovative clinical research and patient-centered care. Located in Jordan, KAUH is committed to enhancing medical knowledge and improving treatment outcomes by conducting rigorous clinical trials across various therapeutic areas. The hospital is equipped with state-of-the-art facilities and a multidisciplinary team of healthcare professionals, ensuring the highest standards of research integrity and participant safety. Through its collaborative approach and focus on evidence-based medicine, KAUH aims to contribute significantly to the global medical community and the well-being of patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Irbid, Jordan
Patients applied
Trial Officials
OLA Al-Batayneh
Principal Investigator
Jordan University of Science and Technology
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported